Clinical Trial Update: Famitinib in Combination With Adebrelimab for the Treatment of Advanced Thyroid Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating famitinib in combination with adequreblimab for advanced thyroid cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)
• Famitinib (Famitinib)

Snippet

Sponsor: Ruijin Hospital | Conditions: Thyroid Cancer | Phase 2 | Status: UNKNOWN